PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1988 October; 81(10): 579–582.
PMCID: PMC1291801

Multimodality detection of metastatic melanoma.

Abstract

A retrospective evaluation of radionuclide liver and spleen scintigraphy (LS), ultrasonography (US), and computed tomography (CT) was performed in 88 patients who had pathologically proven cutaneous melanoma. In patients who had all three examinations (n = 24), the matrix analysis showed that CT was significantly more sensitive (0.94) in detecting intra-abdominal metastasis when compared to US (0.62, P less than 0.05) and LS (0.38, P less than 0.01). Sixty-four patients had only US and LS studies. In this group of patients US was found to be more sensitive than LS, 0.88 and 0.54 respectively (P less than 0.01). Furthermore, when CT was compared with US, CT was shown to detect metastases significantly earlier than US (P = 0.03). Overall, CT provided the most accurate means for detecting the intra-abdominal metastases of cutaneous melanoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (740K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Snow JH, Jr, Goldstein HM, Wallace S. Comparison of scintigraphy, sonography, and computed tomography in the evaluation of hepatic neoplasms. AJR Am J Roentgenol. 1979 Jun;132(6):915–918. [PubMed]
  • Bryan PJ, Dinn WM, Grossman ZD, Wistow BW, McAfee JG, Kieffer SA. Correlation of computed tomography, gray scale ultrasonography, and radionuclide imaging of the liver in detecting space-occupying processes. Radiology. 1977 Aug;124(2):387–393. [PubMed]
  • Doiron MJ, Bernardino ME. A comparison of noninvasive imaging modalities in the melanoma patient. Cancer. 1981 Jun 1;47(11):2581–2584. [PubMed]
  • Strauss AV, Dritschilo A, Carter BL, Nathanson L, Piro AJ. Diagnostic testing for radiation treatment planning of malignant melanoma with special emphasis on CT scanning. Comput Tomogr. 1981 Jan-Mar;5(1):37–42. [PubMed]
  • Banzet P, Jacquillat C, Civatte J, Puissant A, Maral J, Chastang C, Israel L, Belaich S, Jourdain JC, Weil M, et al. Adjuvant chemotherapy in the management of primary malignant melanoma. Cancer. 1978 Apr;41(4):1240–1248. [PubMed]
  • Ashare AB. Radiocolloid liver scintigraphy. A choice and an echo. Radiol Clin North Am. 1980 Aug;18(2):315–319. [PubMed]
  • McClees EC, Gedgaudas-McClees RK. Screening for diffuse and focal liver disease: the case for hepatic scintigraphy. J Clin Ultrasound. 1984 Feb;12(2):75–81. [PubMed]
  • Lewis E. Screening for diffuse and focal liver disease: the case for hepatic sonography. J Clin Ultrasound. 1984 Feb;12(2):67–73. [PubMed]
  • Bernardino ME, Goldstein HM. Gray scale ultrasonography in the evaluation of metastatic melanoma. Cancer. 1978 Dec;42(6):2529–2533. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press